Companies / Viridian Therapeutics, Inc. / Activity
Activity — Viridian Therapeutics, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mahoney Stephen F. CEO | Other | Common Stock | $223.6K | -7K -18.18% | 33,349 0.03% of shares | low |
| Mar 3, 2026 | Mahoney Stephen F. CEO | Other | Common Stock | $223.6K | -8K -18.71% | 33,130 0.03% of shares | low |
| Mar 3, 2026 | Mahoney Stephen F. CEO | Exercise | Restricted Stock Units | — | -18K -25.00% | 55,071 0.05% of shares | low |
| Mar 2, 2026 | Mahoney Stephen F. CEO | Grant | Restricted Stock Units | — | +112K | 111,900 0.10% of shares | low |
| Mar 2, 2026 | Mahoney Stephen F. CEO | Grant | Stock Option (Right to Buy) | — | +560K | 559,600 0.49% of shares | low |
| Mar 3, 2026 | Mahoney Stephen F. CEO | Exercise | Common Stock | — | +18K +81.95% | 40,757 0.04% of shares | low |